Rachel Isaksson Vogel, PhD

Assistant Professor, Department of Obstetrics, Gynecology and Women's Health (OBGYN)

Rachel Isaksson Vogel

Contact Info

isak0023@umn.edu

Fax 612-626-0665

Office Address:
Moos Tower - 12th Floor

Mailing Address:
420 Delaware Street S.E.
MMC 395
Minneapolis, MN 55455

Administrative Assistant Name
Kit Brown

Administrative Phone
612-624-9904

PhD, Epidemiology, University of Minnesota, 2016

MS, Biostatistics, University of Minnesota, 2008

Summary

Dr. Rachel Isaksson Vogel is an Assistant Professor in the Division of Gynecologic Oncology in the Department of Obstetrics, Gynecology and Women’s Health.

Dr. Vogel received her Master’s degree in Biostatistics in 2008 and served as a statistical consultant for cancer researchers through 2015. In 2016 she completed her Ph.D. in Epidemiology at the University of Minnesota and transitioned into a faculty research position.

Dr. Vogel is dedicated to research in women’s cancer and is currently the Masonic Cancer Center’s Women’s Health Research Scholar. She is interested in outcomes research and cancer survivorship. She is closely involved in the design of observational and clinical studies within the Department and serves as a statistical consultant and mentor to the faculty, fellows and residents. 

Research

Research Summary/Interests

Dr. Vogel is the Masonic Cancer Center Women’s Health Research Scholar and is interested in outcomes research and cancer survivorship. As the number of cancer survivors increases, the long-term negative effects of the disease and treatment have become a substantial public health concern. Dr. Vogel recently completed a large study assessing the quality of life and health behaviors of of long-term melanoma survivors. Her current study is to identify risk factors of chemotherapy-induced cognitive decline, often referred to as “chemo brain” among women with ovarian cancer. Her long-term goal is to establish a gynecologic cancer outcomes and survivorship research program focused on improving survivors’ quality of life during and after treatment.

Publications

Vogel RI, Coughlin K, Scotti A, Iizuka Y, Anchoori RK, Roden RBS, Marastoni M, Bazzaro M. “Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells.” Oncotarget. 2015 Feb 28; 6(6): 4159-70. PMID: 25784654. PMCID: PMC4414179.

Isaksson Vogel R, Ahmed RL, Nelson HH, Berwick M, Weinstock MA, Lazovich D. “Association between Indoor Tanning and Melanoma in the Absence of Burns.” Journal of the National Cancer Institute. 2014 Jul 16;106(7). PMID: 25031276. PMCID: PMC4161998.

Isaksson Vogel R, Petzel SV, Cragg J, McClellan M, Chan D, Dickson E, Jacko JA, Sainfort F, Geller MA. “Development and Pilot of an Advance Care Planning Website for Women with Ovarian Cancer: A Randomized Controlled Trial.” Gynecologic Oncology. 2013 Nov; 131(2):430-436. E-pub 2013 Aug. 27. PMID: 23988413. No PMCID.

Koopmeiners J and Isaksson Vogel R. “Early Termination of a Two-Stage Study to Develop and Validate a Panel of Biomarkers.” Statistics in Medicine. 2013 Mar 15; 32(6): 1027-37. PMID: 23413213. PMCID: PMC3888241.

Lazovich D, Isaksson Vogel R, Berwick M, Weinstock M, Anderson K, Warshaw E. “Indoor tanning and risk of melanoma: a case-control study in a highly exposed population”. Cancer Epidemiology, Biomarkers and Prevention June 2010; 19:1557–68. E-pub May 2010. PMID: 20507845. PMCID: PMC2883000.

For a complete list, click here. (http://www.ncbi.nlm.nih.gov/sites/myncbi/1v_Okk5O1sK5-/bibliography/47973995/public/?sort=date&direction=descending